{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:16:27Z","timestamp":1794330987696,"version":"4.9.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65838-1","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:26:31Z","timestamp":1764674791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-3619","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Maetens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Van Baelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-1543","authenticated-orcid":false,"given":"Kristien","family":"Borremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Zels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Geukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amena","family":"Mahdami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Van Brussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-7657","authenticated-orcid":false,"given":"Ha-Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Pabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hava","family":"Izci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Bachir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7921-212X","authenticated-orcid":false,"given":"Camille","family":"Carette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-2628","authenticated-orcid":false,"given":"Sigrid","family":"Hatse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madita","family":"Nysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-6680","authenticated-orcid":false,"given":"Bram","family":"Boeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-302X","authenticated-orcid":false,"given":"Diether","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-5873","authenticated-orcid":false,"given":"Elia","family":"Biganzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1434-9460","authenticated-orcid":false,"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-7837","authenticated-orcid":false,"given":"Hans","family":"Wildiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-3409","authenticated-orcid":false,"given":"Wouter","family":"Van Den Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-2478","authenticated-orcid":false,"given":"Jonas","family":"Demeulemeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2391-5425","authenticated-orcid":false,"given":"Giuseppe","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5223-5579","authenticated-orcid":false,"given":"Christine","family":"Desmedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"65838_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"65838_CR2","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s11845-022-02926-x","volume":"191","author":"D Courtney","year":"2022","unstructured":"Courtney, D. et al. Breast cancer recurrence: factors impacting occurrence and survival. Ir. J. Med. Sci. 191, 2501\u20132510 (2022).","journal-title":"Ir. J. Med. Sci."},{"key":"65838_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Prim. 5, 66 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"65838_CR4","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.esmoop.2022.100409","volume":"7","author":"F Miglietta","year":"2022","unstructured":"Miglietta, F., Bottosso, M., Griguolo, G., Dieci, M. V. & Guarneri, V. Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival. ESMO Open 7, 100409 (2022).","journal-title":"ESMO Open"},{"key":"65838_CR5","doi-asserted-by":"crossref","unstructured":"Al Sukhun, S. et al. Systemic treatment of patients with metastatic breast cancer: ASCO resource\u2013stratified guideline. JCO Glob. Oncol. 10, e2300285 (2024).","DOI":"10.1200\/GO.23.00411"},{"key":"65838_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","volume":"32","author":"A Gennari","year":"2021","unstructured":"Gennari, A. et al. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann. Oncol. 32, 1475\u20131495 (2021).","journal-title":"Ann. Oncol."},{"key":"65838_CR7","first-page":"613","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present. Future Cell 168, 613\u2013628 (2017).","journal-title":"Future Cell"},{"key":"65838_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejca.2023.04.026","volume":"188","author":"T Geukens","year":"2023","unstructured":"Geukens, T. et al. Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer. Eur. J. Cancer 188, 152\u2013160 (2023).","journal-title":"Eur. J. Cancer"},{"key":"65838_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751\u2013759 (2015).","journal-title":"Nat. Med."},{"key":"65838_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17, 223\u2013238 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"65838_CR11","first-page":"2689","volume":"5","author":"G Sozzi","year":"1999","unstructured":"Sozzi, G. et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin. Cancer Res. 5, 2689\u20132692 (1999).","journal-title":"Clin. Cancer Res."},{"key":"65838_CR12","unstructured":"Batool, S. M. et al. The liquid biopsy consortium: challenges and opportunities for early cancer detection and monitoring. Cell Rep. Med. 4, 101198 (2023)."},{"key":"65838_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ajog.2005.01.054","volume":"193","author":"EM Swisher","year":"2005","unstructured":"Swisher, E. M. et al. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Am. J. Obstet. Gynecol. 193, 662\u2013667 (2005).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"65838_CR14","doi-asserted-by":"publisher","first-page":"e2431722","DOI":"10.1001\/jamanetworkopen.2024.31722","volume":"7","author":"K Dickinson","year":"2024","unstructured":"Dickinson, K. et al. Circulating tumor DNA and survival in metastatic breast cancer. JAMA Netw. Open 7, e2431722 (2024).","journal-title":"JAMA Netw. Open"},{"key":"65838_CR15","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, 224ra24\u2013224ra24 (2014).","journal-title":"Sci. Transl. Med."},{"key":"65838_CR16","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-05-2324","volume":"12","author":"H Kimura","year":"2006","unstructured":"Kimura, H. et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin. Cancer Res. 12, 3915\u20133921 (2006).","journal-title":"Clin. Cancer Res."},{"key":"65838_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S1470-2045(20)30444-7","volume":"21","author":"NC Turner","year":"2020","unstructured":"Turner, N. C. et al. Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial. Lancet Oncol. 21, 1296\u20131308 (2020).","journal-title":"Lancet Oncol."},{"key":"65838_CR18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S1470-2045(22)00555-1","volume":"23","author":"F-C Bidard","year":"2022","unstructured":"Bidard, F.-C. et al. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 23, 1367\u20131377 (2022).","journal-title":"Lancet Oncol."},{"key":"65838_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"S-J Dawson","year":"2013","unstructured":"Dawson, S.-J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199\u20131209 (2013).","journal-title":"N. Engl. J. Med."},{"key":"65838_CR20","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdv177","volume":"26","author":"J Tie","year":"2015","unstructured":"Tie, J. et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann. Oncol. 26, 1715\u20131722 (2015).","journal-title":"Ann. Oncol."},{"key":"65838_CR21","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1158\/0008-5472.CAN-18-3402","volume":"79","author":"G Rossi","year":"2019","unstructured":"Rossi, G. & Ignatiadis, M. Promises and pitfalls of using liquid biopsy for precision medicine. Cancer Res. 79, 2798\u20132804 (2019).","journal-title":"Cancer Res."},{"key":"65838_CR22","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/annonc\/mdz227","volume":"30","author":"G Siravegna","year":"2019","unstructured":"Siravegna, G. et al. How liquid biopsies can change clinical practice in oncology. Ann. Oncol. 30, 1580\u20131590 (2019).","journal-title":"Ann. Oncol."},{"key":"65838_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis, M., Sledge, G. W. & Jeffrey, S. S. Liquid biopsy enters the clinic\u2014implementation issues and future challenges. Nat. Rev. Clin. Oncol. 18, 297\u2013312 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65838_CR24","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/annonc\/mdz196","volume":"30","author":"P Hofman","year":"2019","unstructured":"Hofman, P., Heeke, S., Alix-Panabi\u00e8res, C. & Pantel, K. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? Ann. Oncol. 30, 1448\u20131459 (2019).","journal-title":"Ann. Oncol."},{"key":"65838_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","volume":"20","author":"R Lawrence","year":"2023","unstructured":"Lawrence, R., Watters, M., Davies, C. R., Pantel, K. & Lu, Y.-J. Circulating tumour cells for early detection of clinically relevant cancer. Nat. Rev. Clin. Oncol. 20, 487\u2013500 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65838_CR26","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/OP.24.00274","volume":"20","author":"J Xi","year":"2024","unstructured":"Xi, J., Ma, C. X. & O\u2019Shaughnessy, J. Current clinical utility of circulating tumor DNA testing in breast cancer: a practical approach. JCO Oncol. Pract. 20, 1460\u20131470 (2024).","journal-title":"JCO Oncol. Pract."},{"key":"65838_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2217\/fon-2022-1196","volume":"19","author":"N Turner","year":"2023","unstructured":"Turner, N. et al. Design of SERENA-6, a phase III switching trial of camizestrant in ESR1\u2014mutant breast cancer during first-line treatment. Future Oncol. 19, 559\u2013573 (2023).","journal-title":"Future Oncol."},{"key":"65838_CR28","doi-asserted-by":"crossref","unstructured":"Turner, N. C. et al. Camizestrant + CDK4\/6 inhibitor (CDK4\/6i) for the treatment of emergent ESR1 mutations during first-line (1L) endocrine-based therapy (ET) and ahead of disease progression in patients (pts) with HR+\/HER2\u2013 advanced breast cancer (ABC): Phase 3, double-blind ctDNA-guided SERENA-6 trial. J. Clin. Oncol. 43, LBA4 (2025).","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA4"},{"key":"65838_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.annonc.2022.11.005","volume":"34","author":"NC Turner","year":"2023","unstructured":"Turner, N. C. et al. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer. Ann. Oncol. 34, 200\u2013211 (2023).","journal-title":"Ann. Oncol."},{"key":"65838_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1538-7445.SABCS23-PO1-20-05","volume":"84","author":"F Mergel","year":"2024","unstructured":"Mergel, F. et al. Abstract PO1-20-05: SURVIVE study \u2013 a multicenter, randomized, controlled phase 3 superiority trial, evaluating liquid biopsy guided intensified follow-up surveillance in women with intermediate-to high-risk early breast cancer. Cancer Res 84, 20\u201305 (2024).","journal-title":"Cancer Res"},{"key":"65838_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/d41573-023-00111-y","volume":"22","author":"W Xie","year":"2023","unstructured":"Xie, W., Suryaprakash, S., Wu, C., Rodriguez, A. & Fraterman, S. Trends in the use of liquid biopsy in oncology. Nat. Rev. Drug Discov. 22, 612\u2013613 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"65838_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/1535-7163.MCT-16-0436","volume":"16","author":"H Husain","year":"2017","unstructured":"Husain, H. et al. Cell-free DNA from ascites and pleural effusions: molecular insights into genomic aberrations and disease biology. Mol. Cancer Ther. 16, 948\u2013955 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"65838_CR33","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/clinchem\/46.8.1078","volume":"46","author":"I Botezatu","year":"2000","unstructured":"Botezatu, I. et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46, 1078\u20131084 (2000).","journal-title":"Clin. Chem."},{"key":"65838_CR34","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1158\/1078-0432.CCR-08-1112","volume":"14","author":"KCA Chan","year":"2008","unstructured":"Chan, K. C. A., Leung, S. F., Yeung, S. W., Chan, A. T. C. & Lo, Y. M. D. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients. Clin. Cancer Res. 14, 4809 (2008).","journal-title":"Clin. Cancer Res."},{"key":"65838_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-428","volume":"12","author":"KB Sriram","year":"2012","unstructured":"Sriram, K. B. et al. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer 12, 428 (2012).","journal-title":"BMC Cancer"},{"key":"65838_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cncy.22205","volume":"128","author":"SR Yang","year":"2020","unstructured":"Yang, S. R. et al. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathol. 128, 43\u201356 (2020).","journal-title":"Cancer Cytopathol."},{"key":"65838_CR37","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1158\/1078-0432.CCR-07-0220","volume":"13","author":"SK Mithani","year":"2007","unstructured":"Mithani, S. K. et al. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Clin. Cancer Res. 13, 7335\u20137340 (2007).","journal-title":"Clin. Cancer Res."},{"key":"65838_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9839","volume":"6","author":"L De Mattos-Arruda","year":"2015","unstructured":"De Mattos-Arruda, L. et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat. Commun. 6, 1\u20136 (2015).","journal-title":"Nat. Commun."},{"key":"65838_CR39","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-21-3017","volume":"28","author":"A Fitzpatrick","year":"2022","unstructured":"Fitzpatrick, A. et al. Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis. Clin. Cancer Res. 28, 1180\u20131191 (2022).","journal-title":"Clin. Cancer Res."},{"key":"65838_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","volume":"33","author":"J Pascual","year":"2022","unstructured":"Pascual, J. et al. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann. Oncol. 33, 750\u2013768 (2022).","journal-title":"Ann. Oncol."},{"key":"65838_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey, A., Church, M., Rothwell, D., Dive, C. & Cook, N. Circulating tumour DNA\u2014looking beyond the blood. Nat. Rev. Clin. Oncol. 19, 600\u2013612 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65838_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/path.6271","volume":"263","author":"T Geukens","year":"2024","unstructured":"Geukens, T. et al. Research autopsy programmes in oncology: shared experience from 14 centres across the world. J. Pathol. 263, 150\u2013165 (2024).","journal-title":"J. Pathol."},{"key":"65838_CR43","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.trecan.2023.03.002","volume":"9","author":"S Hessey","year":"2023","unstructured":"Hessey, S., Fessas, P., Zaccaria, S., Jamal-Hanjani, M. & Swanton, C. Insights into the metastatic cascade through research autopsies. Trends Cancer 9, 490\u2013502 (2023).","journal-title":"Trends Cancer"},{"key":"65838_CR44","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41568-019-0199-4","volume":"19","author":"CA Iacobuzio-Donahue","year":"2019","unstructured":"Iacobuzio-Donahue, C. A. et al. Cancer biology as revealed by the research autopsy. Nat. Rev. Cancer 19, 686\u2013697 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"65838_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00637-3","volume":"10","author":"T Geukens","year":"2024","unstructured":"Geukens, T. et al. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program. NPJ Breast Cancer 10, 31 (2024).","journal-title":"NPJ Breast Cancer"},{"key":"65838_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.annonc.2022.05.006","volume":"33","author":"K Van Baelen","year":"2022","unstructured":"Van Baelen, K. et al. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Ann. Oncol. 33, 769\u2013785 (2022).","journal-title":"Ann. Oncol."},{"key":"65838_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02794-9","volume":"23","author":"TL Kaufmann","year":"2022","unstructured":"Kaufmann, T. L. et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol. 23, 241 (2022).","journal-title":"Genome Biol."},{"key":"65838_CR48","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1183\/09031936.00171610","volume":"38","author":"T Hirata","year":"2011","unstructured":"Hirata, T. et al. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur. Respir. J. 38, 1425\u20131430 (2011).","journal-title":"Eur. Respir. J."},{"key":"65838_CR49","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl499","volume":"18","author":"AA Ayantunde","year":"2007","unstructured":"Ayantunde, A. A. & Parsons, S. L. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann. Oncol. 18, 945\u2013949 (2007).","journal-title":"Ann. Oncol."},{"key":"65838_CR50","first-page":"37","volume":"3","author":"N Switzer","year":"2015","unstructured":"Switzer, N. et al. Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract. Cancer Treat. Commun. 3, 37\u201343 (2015).","journal-title":"Cancer Treat. Commun."},{"key":"65838_CR51","doi-asserted-by":"publisher","first-page":"e20518","DOI":"10.1200\/JCO.2023.41.16_suppl.e20518","volume":"41","author":"Y Lin","year":"2023","unstructured":"Lin, Y., Ji, S., Jiang, Y. & Wang, T. Comparative analysis of the mutation detection using malignant pleural effusion and blood cell-free DNA samples in lung cancer. J. Clin. Oncol. 41, e20518\u2013e20518 (2023).","journal-title":"J. Clin. Oncol."},{"key":"65838_CR52","doi-asserted-by":"publisher","first-page":"e177759","DOI":"10.1172\/jci.insight.177759","volume":"9","author":"C Bhambhani","year":"2024","unstructured":"Bhambhani, C. et al. ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer. JCI Insight 9, e177759 (2024).","journal-title":"JCI Insight"},{"key":"65838_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cjp2.207","volume":"7","author":"I Erve","year":"2021","unstructured":"Erve, I. et al. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid. J. Pathol. Clin. Res 7, 203\u2013208 (2021).","journal-title":"J. Pathol. Clin. Res"},{"key":"65838_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/mco.2021.2297","volume":"15","author":"Y Akizawa","year":"2021","unstructured":"Akizawa, Y. et al. Ovarian metastasis from breast cancer mimicking a primary ovarian neoplasm: a case report. Mol. Clin. Oncol. 15, 135 (2021).","journal-title":"Mol. Clin. Oncol."},{"key":"65838_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen, B. et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 185, 563\u2013575.e11 (2022).","journal-title":"Cell"},{"key":"65838_CR56","doi-asserted-by":"crossref","unstructured":"Hamilton, J. G., Watsula-Morley, A. & Latham, A. Psychosocial issues related to liquid biopsy for ctDNA in individuals at normal and elevated risk. in Psycho-Oncology (ed Jacobsen, P. B.) 116\u2013118 (Oxford University Press, 2021).","DOI":"10.1093\/med\/9780190097653.003.0017"},{"key":"65838_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36801-9","volume":"14","author":"A Prat","year":"2023","unstructured":"Prat, A. et al. Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nat. Commun. 14, 1157 (2023).","journal-title":"Nat. Commun."},{"key":"65838_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.annonc.2025.01.021","volume":"36","author":"I Garcia-Murillas","year":"2025","unstructured":"Garcia-Murillas, I. et al. Whole genome sequencing-powered ctDNA sequencing for breast cancer detection. Ann. Oncol. 36, 673\u2013681 (2025).","journal-title":"Ann. Oncol."},{"key":"65838_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"65838_CR60","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"65838_CR61","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"65838_CR62","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"65838_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-13-591","volume":"13","author":"G Nilsen","year":"2012","unstructured":"Nilsen, G. et al. Copynumber: efficient algorithms for single- and multi-track copy number segmentation. BMC Genom. 13, 1\u201316 (2012).","journal-title":"BMC Genom."},{"key":"65838_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"65838_CR65","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114 (2014).","journal-title":"Bioinformatics"},{"key":"65838_CR66","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"65838_CR67","unstructured":"Picard Tools - By Broad Institute. https:\/\/broadinstitute.github.io\/picard\/."},{"key":"65838_CR68","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"65838_CR69","doi-asserted-by":"publisher","unstructured":"Benjamin, D. et al. Calling Somatic SNVs and Indels with Mutect2 https:\/\/doi.org\/10.1101\/861054.","DOI":"10.1101\/861054"},{"key":"65838_CR70","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"65838_CR71","doi-asserted-by":"publisher","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 1\u201316 https:\/\/doi.org\/10.1200\/po.17.00011 (2017).","DOI":"10.1200\/po.17.00011"},{"key":"65838_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 1\u201314 (2016).","journal-title":"Genome Biol."},{"key":"65838_CR73","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton, G. M. et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat. Biotechnol. 2013 31, 1023\u20131031 (2013).","journal-title":"Nat. Biotechnol. 2013"},{"key":"65838_CR74","doi-asserted-by":"publisher","unstructured":"Nik-Zainal, S. Landscape of Somatic Mutations in 560 Breast Cancer Whole-Genome Sequences https:\/\/doi.org\/10.1038\/nature17676.","DOI":"10.1038\/nature17676"},{"key":"65838_CR75","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"65838_CR76","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/2159-8290.CD-19-1390","volume":"10","author":"SA Wander","year":"2020","unstructured":"Wander, S. A. et al. The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4\/6 inhibitors in patients with hormone receptor\u2013positive metastatic. Breast Cancer Cancer Discov. 10, 1174\u20131193 (2020).","journal-title":"Breast Cancer Cancer Discov."},{"key":"65838_CR77","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2159-8290.CD-20-1726","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. INK4 tumor suppressor proteins mediate resistance to CDK4\/6 kinase inhibitors. Cancer Discov. 12, 356\u2013371 (2022).","journal-title":"Cancer Discov."},{"key":"65838_CR78","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s42003-025-07606-x","volume":"8","author":"A Ghosh","year":"2025","unstructured":"Ghosh, A. et al. Genomic hallmarks of endocrine therapy resistance in ER\/PR+HER2- breast tumours. Commun. Biol. 8, 207 (2025).","journal-title":"Commun. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65838-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:02:53Z","timestamp":1764680573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65838"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65838-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10826"}}